| My Account | Subscribe | Contact Us | Donate |
Home
- The Edmonton Protocol and Me
- Olympia Dukakis and Her Husband Tackle Type 2
- Surfing with Type 1
- Behind the Wheel, But Still in Control
You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
If you are a physician, educator and medical professional who focus on the treatment of diabetes, then this is the must have resource for you.
Finally! A fresh take on the “professional” journal. Each bi-monthly issue cuts through the jargon and presents the most important information you need to enhance your practice and assist your patients.
Each bi-monthly issue of Diabetes Health Professional is a self-contained handbook covering products, educational resources and the latest diabetes research, complimented by balanced editorial focused on medical news, drug prescription information, clinical practice recommendations and changing treatment options.
Each quarter we send you the latest, most updated research guides, product guides and educational resource guides available for you and your patients.
Each week the Diabetes Health E-Newsletter delivers links to the very latest in news, reviews, blogs and videos from Diabetes Health direct to your inbox.
As a subscriber you'll get access to the amazing Diabetes Health Digital Advantage™ so you can read the current issue of Diabetes Health magazine online wherever you are!
You can cancel your newsletter subscription at anytime by clicking "Unsubscribe" on the bottom of any newsletter you receive
Then enter your new email address in the above form and click "Subscribe"
Latest Type 2 Issues Articles
Prozac May Aid Weight Loss in Elderly Type 2 Patients
Fluoxetine is the generic name for Prozac, the increasingly-popular antidepressant drug. A study published in Diabetic Medicine, May 1995, reported that fluoxetine may help elderly people with type 2 diabetes lose weight.
A double-blind study of 30 obese type 2 patients over age 60 was conducted in Glasgow, Scotland. Those taking fluoxetine lost an average of 5.72 pounds after three months compared with almost zero weight loss in the placebo group.
According to the report, "Improved glycemic control was also demonstrated in the fluoxetine group compared with placebo, initial A1c levels of 8.0% vs. 8.7% falling at six months by 0.9%."
Although no sustained improvement in fasting blood glucose occurred, it was evident that fluoxetine aided short-term weight loss without adverse effects. However, The Physician's Desk Reference indicates that, "In patients with diabetes, [fluoxetine] may alter glycemic control. Hypoglycemia has occurred during therapy with fluoxetine and hyperglycemia has developed following discontinuation of the drug. As is true with many other types of medication, when taken concurrently by patients with diabetes, insulin and/or oral hypoglycemic dosage many need to be adjusted when therapy with fluoxetine is instituted or discontinued."
The PDR Family Guide to Prescription Drugs warns patients, "Unless you are directed to do so by your doctor, do not take [fluoxetine] if you are recovering from a heart attack or if you have kidney or liver disease, or diabetes."
Categories: Geriatrics, Type 2 Issues, Weight Loss
Facebook
MySpace 
Digg
You May Also Be Interested In...
Click Here To View Or Post Comments
Jan 1, 1996 - Not Yet Rated
Email to a Friend
Send a link to this page to your friends and colleagues.